Voloridge Investment Management
EBS icon

Voloridge Investment Management’s Emergent Biosolutions EBS Stock Holding History

Voloridge Investment Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-471,872
Closed -$3.47M – 1441
2023
Q2 		$3.47M Sell
471,872
-189,900
-29% -$1.76M 0.02% 808
2023
Q1 		$6.86M Buy
661,772
+173,891
+36% +$2.1M 0.03% 571
2022
Q4 		$5.76M Buy
487,881
+195,604
+67% +$3.03M 0.03% 597
2022
Q3 		$6.13M Sell
292,277
-33,231
-10% -$925K 0.03% 582
2022
Q2 		$10.1M Buy
325,508
+32,521
+11% +$1.11M 0.05% 433
2022
Q1 		$12M Buy
292,987
+102,046
+53% +$4.5M 0.07% 361
2021
Q4 		$8.3M Buy
190,941
+1,728
+0.9% +$78.2K 0.05% 523
2021
Q3 		$9.47M Sell
189,213
-7,814
-4% -$473K 0.06% 455
2021
Q2 		$12.4M Buy
+197,027
New +$12.7M 0.09% 327
2020
Q4 		– Sell
-87,748
Closed -$9.07M – 1376
2020
Q3 		$9.07M Buy
87,748
+83,036
+1,762% +$8.95M 0.08% 280
2020
Q2 		$373K Sell
4,712
-5,871
-55% -$438K ﹤0.01% 1088
2020
Q1 		$612K Buy
10,583
+3,955
+60% +$228K 0.02% 647
2019
Q4 		$358K Sell
6,628
-26,696
-80% -$1.45M 0.01% 889
2019
Q3 		$1.74M Buy
33,324
+17,458
+110% +$813K 0.03% 493
2019
Q2 		$766K Buy
+15,866
New +$760K 0.02% 499

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Voloridge Investment Management's EBS Position: Q3 2023 in Review

Voloridge Investment Management sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 471,872 shares — an estimated $3.47M sold.

Voloridge Investment Management first reported a position in EBS in Q2 2019 and held it in 15 quarters. The position peaked at $12.4M in Q2 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

  • Voloridge Investment Management reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 471,872 Emergent Biosolutions shares in Q3 2023, an estimated $3.47M.
  • Voloridge Investment Management first reported a position in Emergent Biosolutions in Q2 2019 and held it in 15 quarters.
  • Voloridge Investment Management's Emergent Biosolutions position peaked at $12.4M in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Voloridge Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.